Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan

Yu-Xin Xiao, Kuang-Hung Liu, Wan-Hsuan Lin, T.m. Chan, Ruwen JouScientific 2023 · DOI

TL;DR

This study validates Whole-Genome Sequencing (WGS) using the TGS-TB tool for predicting drug resistance in Mycobacterium tuberculosis isolates from Taiwan, showing high concordance with traditional phenotypic testing. This work establishes WGS as a powerful, comprehensive tool for guiding precision TB therapies in the region.

What Problem Does This Paper Address?

Drug-resistant tuberculosis (DR-TB) remains a significant global health challenge, and accurate, timely diagnosis is crucial for effective treatment and control. While Whole-Genome Sequencing (WGS) is increasingly recommended for predicting drug resistance, data from Taiwan were lacking. Traditional phenotypic drug susceptibility testing (DST) is time-consuming and labor-intensive. Rapid molecular tests exist but have limitations in detecting all resistance mechanisms or low-frequency mutations. WGS offers a more comprehensive approach, but its performance and utility in the Taiwanese context needed to be established.

Methods

The researchers collected 200 Mycobacterium tuberculosis isolates from confirmed DR-TB cases in Taiwan. They performed both:

  • Phenotypic Drug Susceptibility Testing (pDST): This involved culturing the bacteria and exposing them to various anti-TB drugs to determine resistance levels.
  • Whole-Genome Sequencing (WGS): DNA was extracted from the isolates, and sequencing libraries were prepared for Illumina sequencing.
  • Bioinformatic Analysis: The WGS data was analyzed using the Total Genotyping Solution for TB (TGS-TB) tool to predict drug resistance profiles and identify M. tuberculosis lineages. This tool is particularly noted for its focus on the Beijing genotype, prevalent in East Asia.

The WGS-based predictions were then compared against the pDST results to assess concordance, sensitivity, and specificity. Minimum Inhibitory Concentration (MIC) testing was also performed to correlate specific mutations with resistance levels.

Datasets

The study utilized a dataset of 200 Mycobacterium tuberculosis isolates collected from DR-TB cases in Taiwan between 2013 and 2016. These isolates were characterized by both phenotypic DST and whole-genome sequencing. The study did not introduce a new benchmark dataset but rather evaluated WGS performance on a real-world clinical isolate collection.

Key Insights and Ideas

  • WGS as a Reliable Diagnostic Tool: The study strongly supports WGS as a highly accurate method for predicting drug resistance in M. tuberculosis, with excellent concordance for most key drugs.
  • Lineage-Specific Resistance Patterns: The research identified specific mutations associated with particular M. tuberculosis lineages (e.g., RIF rpoB S450L with lineage 2, RIF rpoB H445Y with lineage 1), highlighting the importance of considering both genetic background and resistance mutations.
  • Understanding Discordance: Lower concordance rates for certain drugs (ethambutol, streptomycin, ethionamide) were attributed to factors like mutations conferring low-level resistance, clinical breakpoint limitations in pDST, and potentially unknown resistance mechanisms.
  • Novel Mutation Discovery: The study identified novel mutations that improved the WGS prediction accuracy for certain drugs, underscoring the ongoing need to update mutation databases.
  • Geographic Distribution of Lineages: The research mapped the geographic distribution of different M. tuberculosis lineages across Taiwan, revealing regional variations.

Key Results

  • High Concordance: WGS-based prediction showed high concordance rates, ranging from 84.0% (ethionamide) to 99.5% (fluoroquinolones, amikacin, and PAS). The overall concordance was 94.9%.
  • Specific Drug Concordance: Notable high concordance rates were observed for isoniazid (95.0%), rifampicin (98.0%), pyrazinamide (98.5%), and fluoroquinolones (99.5%).
  • Lineage Distribution: Lineage 2 (East Asian) was the predominant lineage (66.0%), followed by lineage 4 (Euro-American) (26.0%).
  • Lineage Associations: Lineage 2 isolates showed significantly higher resistance to ethambutol and streptomycin compared to lineages 1 and 4. Lineage 1 isolates were more resistant to ethionamide.
  • MIC Correlation: Key mutations like RIF rpoB S450L, FQs gyrA D94G, and SLIDs rrs a1401g were confirmed to confer high resistance levels.

Limitations and Future Work

  • Low Resistance Rates: The study noted limitations due to low resistance rates for certain drugs (KM, AMK, CM, PAS), which reduced the statistical power for evaluating WGS performance for these drugs.
  • No MIC Testing for PZA/CM: The absence of MIC testing for pyrazinamide and capreomycin prevented a direct comparison of WGS predictions with phenotypic resistance levels for these drugs.
  • Lineage Influence: The impact of lineage on WGS prediction accuracy was not fully accounted for in the analysis.
  • Beyond Genetically Encoded Resistance: The authors acknowledge that factors beyond genetic mutations, such as changes in transcription or translation, can influence antibiotic tolerance and persistence, impacting treatment efficacy.

Future work could involve expanding WGS services to include other drug-resistant patterns and integrating WGS into routine TB laboratory services for a streamlined diagnostic policy. The study also suggests the potential for WGS to inform clinical and public health actions more broadly.

Summary updated

Abstract

Drug-resistant tuberculosis (DR-TB) posed challenges to global TB control. Whole-genome sequencing (WGS) is recommended for predicting drug resistance to guide DR-TB treatment and management. Nevertheless, data are lacking in Taiwan. Phenotypic drug susceptibility testing (DST) of 12 anti-TB drugs was performed for 200 Mycobacterium tuberculosis isolates. WGS was performed using the Illumina platform. Drug resistance profiles and lineages were predicted in silico using the Total Genotyping Solution for TB (TGS-TB). Using the phenotypic DST results as a reference, WGS-based prediction demonstrated high concordance rates of isoniazid (95.0%), rifampicin (RIF) (98.0%), pyrazinamide (98.5%) and fluoroquinolones (FQs) (99.5%) and 96.0% to 99.5% for second-line injectable drugs (SLIDs); whereas, lower concordance rates of ethambutol (87.5%), streptomycin (88.0%) and ethionamide (84.0%). Furthermore, minimum inhibitory concentrations confirmed that RIF rpoB S450L, FQs gyrA D94G and SLIDs rrs a1401g conferred high resistance levels. Besides, we identified lineage-associated mutations in lineage 1 (rpoB H445Y and fabG1 c-15t) and predominant lineage 2 (rpoB S450L and rpsL K43R). The WGS-based prediction of drug resistance is highly concordant with phenotypic DST results and can provide comprehensive genetic information to guide DR-TB precision therapies in Taiwan.
BibTeX
@inproceedings{xiao2023whole,
  author = {Yu-Xin Xiao and Kuang-Hung Liu and Wan-Hsuan Lin and T.M. Chan and Ruwen Jou},
  title = {{Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan}},
  booktitle = {Scientific},
  year = {2023},
  doi = {10.1038/s41598-023-29652-3},
}
Figure